{
  "id" : "ss2018_intracranial_gland_98794",
  "algorithm" : "eod_public",
  "version" : "3.2",
  "name" : "SS2018: Intracranial Gland",
  "title" : "Summary Stage 2018: Intracranial Gland",
  "subtitle" : "Summary Stage 2018",
  "notes" : "**Intracranial Gland**\n\n**Any behavior:** \n* 8000-8700, 8720-8790, 8900, 9064, 9070-9071, 9080, 9084-9085, 9100, 9120, 9140, 9220, 9362, 9380-9539, 9680, 9699, 9702-9715, 9751-9759\n\n* 8710, 8712-8714, 8803, 8812-8814, 8816-8824, 8826-8831, 8834-8836, 8841-8842, 8851, 8853, 8855-8857, 8860-8881, 8891-8898, 8902-8905, 8921, 8932-8934, 8940-8990, 9000-9016, 9030, 9042, 9045-9063, 9065, 9072-9073, 9081-9083, 9086-9091, 9101-9111, 9121-9132, 9135, 9137-9138, 9141-9175, 9181-9213, 9221, 9230, 9240-9250, 9252-9361, 9363, 9365, 9370-9373, 9541, 9550, 9560, 9562-9571, 9582) (2023+)\n  * For years 2018-2022, see *Soft Tissue*\n* 9362 (C753 only) (2018-2022 only)\n  *  For 2023+, see *Medulloblastoma*\n* 9671 (2023+)\n  * For years 2018-2022, see *Myeloma and Plasma Cell Disorders*\n* 9690, 9719 (2023+)\n  * For years 2018-2022, see *Lymphoma*\n\n**Benign/Borderline histologies (/0, /1):** \n* 8711, 8800-8802, 8804-8811, 8815, 8825, 8832-8833, 8840, 8850, 8852, 8854, 8858-8859, 8890, 8901, 8910-8920, 8930-8931, 8935-8936, 8991, 9020, 9040-9041, 9043-9044, 9133, 9136, 9180, 9222, 9231, 9251, 9364, 9366-9368, 9540, 9542, 9561, 9580-9581, 9590-9663, 9673-9679, 9687-9689, 9691-9698, 9700-9701, 9716-9718, 9724-9742, 9761-9765, 9767-9993\n\nC751-C753\nC751 Pituitary gland\nC752 Craniopharyngeal duct\nC753 Pineal Gland\n\n**Note 1:** **Sources used in the development of this chapter**\n* SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998) (https://seer.cancer.gov/archive/manuals/EOD10Dig.3rd.pdf)\n* SEER Summary Staging Manual-2000: Codes and Coding Instructions (https://seer.cancer.gov/tools/ssm/ssm2000/)\n* Collaborative Stage Data Collection System, version 02.05:  https://cancerstaging.org/cstage/Pages/default.aspx \n* Chapter 72 *Brain and Spinal Cord*, in the AJCC Cancer Staging Manual, Eighth Edition (2017) published by Springer International Publishing. Used with permission of the American College of Surgeons, Chicago, Illinois.\n* Brain and Spinal Cord, from the AJCC Cancer Staging System Version 9 (2022). Used with permission of the American College of Surgeons, Chicago, Illinois.\n\n**Note 2:** **Medulloblastoma** \n* For diagnoses January 1, 2023, and forward, see the following Summary Stage chapter for the listed histologies (any behavior)\n  * 9362 (C753 only): *Medulloblastoma*\n\n**Note 3:** **Other Summary Stage Chapters with Intracranial Gland sites (/3 only)**\n* **GIST**: 8935-8936\n * **Lymphoma**: 9590, 9596-9663, 9673-9679, 9687-9698, 9716-9719, 9725-9726, 9735, 9737-9738, 9826-9827\n    * *Note:* 9690, 9719 for 2023+ only\n* **Mycosis Fungoides**: 9700-9701\n* **Plasma Cell Disorders**: 9671, 9731, 9734, 9761: \n    * *Note:* 9671 for 2023+ only\n* **Soft Tissue**: 8711, 8800-8802, 8804-8806, 8810-8811, 8815, 8825, 8832-8833, 8840, 8850, 8852, 8854, 8858-8859, 8890, 8901, 8910, 8912, 8920, 8930-8931, 8991, 9020, 9040-9041, 9043-, 9133, 9136, 9180, 9222, 9231, 9251, 9364, 9366-9368, 9540, 9542, 9561, 9580-9581\n\n**Note 4:** **Summary Stage** \n* Summary Stage is the only applicable staging system for this site/histology/schema.\n\n**Note 5:** **Benign/borderline tumors** \n* Benign (/0) or Borderline (/1) tumors **are always coded to 8** regardless of size, extension to adjacent sites, or multiple tumors\n\n**Note 6:** **Not applicable codes**\n* Codes 3 and 4 are not applicable for this chapter.",
  "footnotes" : "(1) Fritz AG, Ries LAG (eds). **SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998)**, National Cancer Institute, NIH Pub. No. 98-2313, Bethesda, MD, 1998\n\n(2) Young JL Jr, Roffers SD, Ries LAG, Fritz AG, Hurlbut AA (eds.). **SEER Summary Staging Manual-2000: Codes and Coding Instructions**, National Cancer Institute, NIH Pub. No. 01-4969, Bethesda, MD, 2001.\n\n(3) Collaborative Stage Work Group of the American Joint Committee on Cancer. **Collaborative Stage Data Collection System User Documentation and Coding Instructions, version 02.05.** American Joint Committee on Cancer (Chicago, IL)\n\n(4) Laws, E.R., Curran, W.J., et al. **Brain and Spinal Cord**. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017\n\n(5) **Brain and Spinal Cord**, from the AJCC Cancer Staging System Version 9 (2022). Used with permission of the American College of Surgeons, Chicago, Illinois.",
  "last_modified" : "2024-05-15T21:39:37.383Z",
  "definition" : [ {
    "key" : "ss2018",
    "name" : "SS2018",
    "type" : "INPUT"
  }, {
    "key" : "description",
    "name" : "Description",
    "type" : "DESCRIPTION"
  } ],
  "rows" : [ [ "0", "**In situ, intraepithelial, noninvasive**" ], [ "1", "**Localized only (localized, NOS)**\n- Confined to gland of origin" ], [ "2", "**Regional by direct extension only**\n- Adjacent connective/soft tissue\n- Adjacent organ(s)/structure(s) for  pituitary and craniopharyngeal duct\n    + Cavernous sinus\n    + Infundibulum\n    + Pons\n    + Sphenoid body and sinuses\n- Adjacent organ(s)/structure(s) for pineal\n    + Infratentorial and central brain" ], [ "7", "**Distant site(s)/lymph node(s) involved**\n- Distant site(s) (including further contiguous extension) \n- Distant lymph node(s), NOS\n- Distant metastasis, NOS\n  + Carcinomatosis \n  + Distant metastasis WITH or WITHOUT distant lymph node(s)" ], [ "8", "**Benign or borderline brain**\n* Behavior is /0 or /1" ], [ "9", "Unknown if extension or metastasis" ] ]
}